 |
 |
|
 |
| SPOT ON | |
Pharmaceutical industry-funded research - potential for manipulation | |
| NEW ON THE MARKET | |
Nothing new - indacaterol (ONBREZ) for COPD | |
| THERAPY FROM A CRITICAL VIEWPOINT | |
Doubts over data on oseltamivir (TAMIFLU) | |
| a-t READER'S QUESTIONS AND COMMENTS | |
Coenzyme Q10: during statin treatment required? | |
 |
|
| IN BRIEF | |
Ginkgo biloba (TEBONIN, generics) without effect on cognitive decline | |
| CURRENT ADR NETWORK REPORT | |
Allergic vasculitis due to tolperisone (e.g. MYDOCALM) | |
| SIDE EFFECTS | |
Chitosan (e.g. FORMOLINE L112) interactions | |
| e a-t IN THE INTERNET | |
Baclofen (LIORESAL) in alcohol dependence? | |
|
© arznei-telegramm 1/2010 | ||
 |  | |